Clinical effectiveness of influenza vaccination in patients with rheumatoid arthritis

International Journal of Rheumatic Diseases

Volumn 21, Issue 6, 2018, Pages 1246-1253

  Chen, Chun Ming ^a   Chen, Hsuan Ju ^b,c   Chen, Wei Shan ^b,c   Lin, Che Chen ^d   Hsu, Chih Cheng ^e,f   Hsu, Yueh Han ^a,b,g  

^a CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^f MIN SHENG GENERAL HOSPITAL   (Taiwan)

^g MIN HWEI COLLEGE OF HEALTH CARE MANAGEMENT   (Taiwan)

Author keywords

autoimmune disease; disease modifying anti rheumatic drugs; effectiveness; influenza vaccination; rheumatoid arthritis

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLUENZA VACCINE; METHOTREXATE; PREDNISOLONE; RITUXIMAB; ANTIRHEUMATIC AGENT;

ADULT; AGED; AGING; ARTICLE; BACTEREMIA; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HAZARD RATIO; HOSPITALIZATION; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; MORTALITY; MORTALITY RISK; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK FACTOR; RISK REDUCTION; SEASONAL INFLUENZA; SEPTICEMIA; TAIWAN; VIREMIA; YOUNG ADULT; ADOLESCENT; AGE; CHI SQUARE DISTRIBUTION; EPIDEMIOLOGY; FACTUAL DATABASE; IMMUNOLOGY; INFLUENZA; TIME FACTOR; TREATMENT OUTCOME; VACCINATION; VIROLOGY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CHI-SQUARE DISTRIBUTION; DATABASES, FACTUAL; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN; TIME FACTORS; TREATMENT OUTCOME; VACCINATION; YOUNG ADULT;

EID: 85048304153     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.13322     Document Type: Article

References (33)

1. Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423, 356–61.
2. See LC, Kuo CF, Chou IJ, Chiou MJ, Yu KH (2013) Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study. Semin Arthritis Rheum 43, 381–6.
3. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46, 2287–93.
4. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE (2002) Predictors of infection in rheumatoid arthritis. Arthritis Rheum 46, 2294–300.
5. Smitten AL, Choi HK, Hochberg MC et al. (2008) The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol 35, 387–93.
6. van den Hoek J, Boshuizen HC, Roorda LD et al. (2017) Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study. Rheumatol Int 37, 487–93.
7. Centers for Disease Control and Prevention (2010) Estimates of deaths associated with seasonal influenza-United States, 1976–2007. Morb Mortal Wkly Rep 59, 1057–62.
8. Mullooly JP, Bridges CB, Thompson WW et al. (2007) Influenza- and RSV-associated hospitalizations among adults. Vaccine 25, 846–55.
9. World Health Organization (2016) Influenza (seasonal)-Fact sheet No 211 [homepage on the Internet]. [updated 2016 May; cited 2016 Jun 9]. Available from: http://www.who.int/mediacentre/factsheets/fs211/en/.
10. Grohskopf LA, Sokolow LZ, Broder KR et al. (2016) Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep 65, 1–54.
11. Singh JA, Saag KG, Bridges SL Jr et al. (2016) 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 68, 1–26.
12. Friedman MA, Winthrop K (2016) Vaccinations for rheumatoid arthritis. Curr Opin Rheumatol 28, 330–6.
13. Kobashigawa T, Nakajima A, Taniguchi A et al. (2013) Vaccination against seasonal influenza is effective in Japanese patients with rheumatoid arthritis enrolled in a large observational cohort. Scand J Rheumatol 42, 445–50.
14. Cheng SH, Chiang TL (1997) The effect of universal health insurance on health care utilization in Taiwan. Results from a natural experiment. JAMA 278, 89–93.
15. Insurance BoNH (2013) Regulations for Exempting NHI Insured Persons from the Co-Payment [homepage on the Internet]. [updated 2015 Jul 19; cited 2016 Jun 8]. Available from http://www.nhi.gov.tw/webdata/webdata. aspx?menu=17&menu_id=660&WD_ID=674&webdata_id=2431.
16. Arnett FC, Edworthy SM, Bloch DA et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31, 315–24.
17. Centers of Disease Control T (2017)?[homepage on the Internet]. [updated 2017 Jul 24; cited 2018 April 3]. Available from: http://www.cdc.gov.tw/professional/info.aspx?treeid=9b400d 6bafe34857&nowtreeid=ed3d7db97845c0b6&tid=67E0B940ECC21665.
18. Centers of Disease Control T (2018), [homepage on the Internet]. [updated 2018 April 3; cited 2018 April 3]. Available from: http://www.cdc.gov.tw/submenu.aspx?treeid=1f07e8862ba550cf&nowtreeid=bcc260c5073450d7.
19. Hayden FG (1997) Prevention and treatment of influenza in immunocompromised patients. Am J Med 102, 55–60; discussion 75–6.
20. Fomin I, Caspi D, Levy V et al. (2006) Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis 65, 191–4.
21. Gluck T, Muller-Ladner U (2008) Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis 46, 1459–65.
22. van Assen S, Agmon-Levin N, Elkayam O et al. (2011) EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 70, 414–22.
23. Fekete A, Soos L, Szekanecz Z et al. (2007) Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses. J Autoimmun 29, 154–63.
24. Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE (2010) Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2, CD004876.
25. Demicheli V, Jefferson T, Al-Ansary LA, Ferroni E, Rivetti A, Di Pietrantonj C (2014) Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 3, CD001269.
26. Remschmidt C, Wichmann O, Harder T (2015) Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis. BMC Med 13, 53.
27. Wang IK, Lin CL, Lin PC et al. (2013) Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study. PLoS ONE 8, e58317.
28. Chang CC, Chang YS, Chen WS, Chen YH, Chen JH (2016) Effects of annual influenza vaccination on morbidity and mortality in patients with Systemic Lupus Erythematosus: a Nationwide Cohort Study. Sci Rep 6, 37817.
29. Hmamouchi I, Winthrop K, Launay O, Dougados M (2015) Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort. Vaccine 33, 1446–52.
30. Luque Ramos A, Hoffmann F, Callhoff J, Zink A, Albrecht K (2016) Influenza and pneumococcal vaccination in patients with rheumatoid arthritis in comparison with age- and sex-matched controls: results of a claims data analysis. Rheumatol Int 36, 1255–63.
31. Centers of Disease Control T (2011) [homepage on the Internet]. [updated 2011 Jun 15; cited 2016 Jun 9]. Available from http://www.cdc.gov.tw/professional/info.aspx?treeid=15ea1948ffc4fa7a&nowtreeid=aec97ad890bd4826&tid=F9A10519E5794FE9.
32. Palache A (2011) Seasonal influenza vaccine provision in 157 countries (2004–2009) and the potential influence of national public health policies. Vaccine 29, 9459–66.
33. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS (2006) Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 35, 337–44.